Ascentawits
Ascentawits focuses on developing small molecule targeted conjugated anti-tumor drugs.
Operating in biotechnology, medical, pharmaceutical, product research based in Asia-Pacific (APAC), Ascentawits was founded in 2017.
Within the biotechnology, medical, pharmaceutical, product research space, the company focuses on its core offering rather than a broad product line.
The business is associated with Asia-Pacific (APAC).
Directory data places it at the Series_A stage.
Recorded headcount: c_00051_00100 employees.
It has disclosed roughly $200M in funding.
| Sector | Biotechnology, Medical, Pharmaceutical, Product Research |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2017 |
| Employees | c_00051_00100 |
| Stage | series_a |
| Total funding | $200,000,000 |
Website: www.ascentawits.com
Browse related
Emails and contact routes are reserved for registered members.
Create a free account
Create a free account